Low-Molecular-Weight Heparin Benefited Outpatients with High Risk of Venous Thromboembolism Early in COVID-19 PandemicsRiitta Lassila, Markku Mäkijärvi, Kerstin Carlsson et al.|Blood|2024Cited by 1
Early outpatient use of low-molecular-weight heparin benefits COVID-19 outcome in association with hospitalization - Lessons learnedMiika Koskinen, Eeva Ruotsalainen, Mia Wallin et al.|Thrombosis Research|2025Cited by 0
Strengthening military preparedness and public safety through research and collaboration on infectious disease transmission epidemiological systemsKimmo Parhiala, Miika Koskinen, Jarno Mikkonen et al.|BMJ Military Health|2026Cited by 0